Multinational Etoricoxib and Diclofenac Arthritis Long-Term (MEDAL) Study Program: Cardiovascular Outcomes Following Long-Term Treatment With Etoricoxib Versus Diclofenac in Patients With Osteoarthritis and Rheumatoid Arthritis